"Giovanni XXIII" Cancer Research Center, Institute of General Pathology, Catholic University of the Sacred Hearth, Rome, Italy.
Eur Rev Med Pharmacol Sci. 2010 Apr;14(4):263-8.
Mounting evidence indicates a link between inflammation and cancer. However, the molecular mechanism(s) remains unclear. Indeed, although preclinical and clinical studies suggest that chronic inflammation can promote cancer development, the role(s) of inflammation in the process is likely very complex and far to be completely understood. Inflammation can promote all stages of tumor development through multiple mechanisms which include enhanced proliferation and resistance to apoptosis of initiated cells, induction of DNA mutations, promotion of angiogenesis, invasion and metastasis. On the other hand, components of tumor microenviroment, including tumor cells themselves, may promote an inflammatory state by producing inflammatory mediators. Moreover, while chronic inflammation might promote tumor formation, acute inflammation might well hamper the process and is indeed used therapeutically to inhibit tumor formation.
The present review briefly highlights the relationship between inflammation and tumorigenesis and discusses the possibility to develop chemoprevention and/or therapeutical approaches targeting components of the inflammatory responses.
越来越多的证据表明炎症与癌症之间存在关联。然而,其分子机制尚不清楚。事实上,尽管临床前和临床研究表明慢性炎症可能促进癌症的发展,但炎症在这一过程中的作用可能非常复杂,远未被完全理解。炎症可以通过多种机制促进肿瘤发展的所有阶段,包括增强起始细胞的增殖和抗凋亡能力、诱导 DNA 突变、促进血管生成、侵袭和转移。另一方面,肿瘤微环境的组成部分,包括肿瘤细胞本身,可能通过产生炎症介质来促进炎症状态。此外,虽然慢性炎症可能促进肿瘤形成,但急性炎症可能会阻碍这一过程,事实上,人们正在利用它来进行治疗以抑制肿瘤形成。
本综述简要强调了炎症与肿瘤发生之间的关系,并讨论了针对炎症反应成分开发化学预防和/或治疗方法的可能性。